The purpose of this pilot research is to test the feasibility of two interventions focused on either reducing total calorie intake or reducing the total time that calories are ingested each day in older adults. Participation in this research will involve visits to our clinic for testing and weekly intervention visits (in-person or remote depending on group assignment) for nine months with total participation lasting about a year.
This pilot study is part of a larger planning process to design a full-scale randomized trial to evaluate the long-term effects of caloric restriction (CR) and time restricted eating (TRE) on the health of older adults. The specific objective of the HALLO-P is to collect data to inform the design of the full-scale randomized trial to evaluate the long-term effects of caloric restriction and time restricted eating in older adults. The pilot is a 9-month clinical trial. The pilot data will be used to refine recruitment criteria, estimate recruitment yields, and refine intervention approaches.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
90
20% CR delivered in-person by dietitian/coach
20% reduction in caloric intake, meeting schedule, and physical activity goal delivered remotely.
8-hour TRE with ad libitum caloric intake. This group will undergo a 9-month dietary intervention targeting consumption of all daily caloric intake within an 8-hour window of time, with no restrictions on caloric intake.
Atrium Health Wake Forest Baptist Hospital
Winston-Salem, North Carolina, United States
Number of Participants That Sustained >10% Caloric Restriction
Ability of participants to sustain Caloric Restriction \>10%
Time frame: Month 9
Ability to Maintain Time Restricted Eating (TRE) Intervention
This will measure the sustainability in a 9 month period of time and will be reported as the percentage of day eating within \<= 8.5 hour window which is pre-specified for each participant.
Time frame: Month 9
Number of Participants Who Were Retained
Retention \> 85%
Time frame: Month 9
Body Weight Change
Assessed using home scales.
Time frame: From Baseline to Month 6, and From Baseline to 9 Months
Changes in Fat Mass
Assessed by (Dual-Energy X-Ray Absorptiometry) DXA.
Time frame: From Baseline to Month 9
Changes in Lean Body Mass
As assessed by DXA for the total lean body mass.
Time frame: From Baseline to Month 9
Change in Bone Mineral Density
As assessed by DXA using the Hip BMD
Time frame: From Baseline to Month 9
Change in Resting Energy Expenditure
As assessed by Indirect Calorimetry between baseline and 9 months follow-up
Time frame: From Baseline to Month 9
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in Physical Activity Energy Expenditure
Assessed by ActivPAL
Time frame: From Baseline to Month 9
Change in Energy Intake
Using doubly-labeled water (DLW). Energy intake will be calculated from Total Energy Expenditure (TEE) assessed by DLW and change in body energy stores (measured by body weight and/or DXA) according to the equation: Energy Intake = TEE + Change in body energy stores
Time frame: From Baseline to Month 9
Change in Total Muscle Mass
The D3-Creatine (D3Cr) method used to assess total muscle mass is completed after the participant ingests a known amount of D3-creatine (creatine with deuterium atoms replacing hydrogens) and the labeled creatine is distributed throughout the body, with approximately 98% ending up in skeletal muscle. By measuring the ratio of labeled (D3-creatinine) to unlabeled creatinine in a urine sample the total body creatine pool can be determined and total muscle mass can be calculated.
Time frame: From Baseline to Month 9
Change in Self-Reported Energy Intake
Data will be collected and nutrients and food groups analyzed using the publicly available National Cancer Institute's Automated Self-Administered 24-Hour (ASA24) dietary assessment tool.
Time frame: From Baseline to Month 9
Physical Function--Change in Walk Time
400m walk - assessed in number of seconds (unlimited time)
Time frame: From Baseline to Month 9
Physical Function--Change in Grip Strength
measured in kg (0-90kg)
Time frame: From Baseline to Month 9
Physical Function--Change in eSPPB
Change in overall physical performance with total score ranging from 0 to 4 with a higher score denoting better physical function.
Time frame: From Baseline to Month 9
Change in Cognitive Function--MoCA
Total score ranges from 0-30 with a higher score denoting better cognitive function.
Time frame: From baseline to Month 9
Change in Age-Related Biomarkers--Fasting Insulin
Fasting insulin, an age-related biomarker
Time frame: From Baseline to 9 Months
Change in Age-Related Biomarkers--interleukin-6 (IL-6)
Interleukin-6 (IL-6) is an Age-related biomarker, cytokine, and key mediator of inflammation
Time frame: From Baseline to 9 Months
Change in Age-Related Biomarkers--tumor Necrosis Factor Soluble Receptor I (TNFRI)
Tumor Necrosis Factor Receptor 1 (TNRFI), an Age-Related Biomarker, is a protein that acts as a receptor for TNF-alpha, a cytokin involved in inflammation.
Time frame: From Baseline to 9 Months
Change in Age-Related Biomarkers--cystatin C
Change in cystatin C - An Age-Related Biomarker used to assess kidney function
Time frame: From Baseline to 9 Months
Change in Age-Related Biomarkers-- CRP From Serum
Change in C-reactive Protein, an Age-Related Biomarker that is used to detect inflammation in the body
Time frame: From Baseline to 9 Months